Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Acadia Healthcare Q4 2025 Revenue Up 6.1%

Acadia Healthcare Company, Inc. ("Acadia") has released its financial results for the fourth quarter and full year ended December 31, 2025, along with guidance for the full year 2026. The company reported that its revenue for the fourth quarter of 2025 totaled $821.5 million, marking a 6.1% increase compared with the fourth quarter of 2024. For the full year 2025, revenue amounted to $3,312.8 million, reflecting a 5.0% increase compared with the prior year.

The company experienced a net loss attributable to Acadia of $(13.02) per diluted share for the fourth quarter of 2025, as opposed to net income of $0.35 per diluted share in the prior-year period. Adjusted net income attributable to Acadia for the same period was $6.1 million, or $0.07 per diluted share, compared with $59.2 million, or $0.64 per diluted share in the prior-year period. Moreover, the adjusted EBITDA for the fourth quarter of 2025 was $99.8 million, down from $153.1 million in the prior-year period, and at the upper end of the company’s implied fourth-quarter guidance range.

In terms of facility revenue, Acute Inpatient Psychiatric Facilities saw a 10% increase in revenue, while Specialty Treatment Facilities experienced a 4% decrease and Comprehensive Treatment Centers and Residential Treatment Centers saw 5% and 3% increases, respectively, compared to the prior year's fourth quarter.

Acadia added 181 newly licensed beds during the fourth quarter, including 37 beds to existing facilities and 144 beds from new facilities opened in the quarter. For the full year 2025, the company added 1,089 licensed beds, including 311 to existing facilities and 778 beds from new facilities opened during the year.

Looking ahead to the full year 2026, Acadia is projecting revenue in the range of $3.37 to $3.45 billion, adjusted EBITDA of $575 to $610 million, and adjusted earnings per diluted share of $1.30 to $1.55. The company's full-year guidance includes assumptions related to same-facility volume growth, revenue per patient day growth, and startup losses, among others.

Acadia is a leading provider of behavioral healthcare services across the United States, operating a network of 277 behavioral healthcare facilities with over 12,500 beds in 40 states and Puerto Rico as of December 31, 2025. Today the company's shares have moved -1.93% to a price of $11.68. For the full picture, make sure to review Acadia Healthcare's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS